Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF JANUARY 14, 2007 FBO #1875
SPECIAL NOTICE

D -- Request for Information (RFI) for BioSense Program

Notice Date
1/12/2007
 
Notice Type
Special Notice
 
NAICS
541990 — All Other Professional, Scientific, and Technical Services
 
Contracting Office
Department of Health and Human Services, Center for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, GA, 30341-4146, UNITED STATES
 
ZIP Code
00000
 
Solicitation Number
BioSenseRFI
 
Response Due
1/29/2007
 
Archive Date
2/13/2007
 
Description
SUMMARY: This is a request for information only. It is not a request for proposals and does not commit the Government to issue a solicitation, make an award, or pay any costs associated with responding to this announcement. All submitted information shall remain with the Government and will not be returned. The Centers for Disease Control and Prevention (CDC), National Center for Public Health Informatics (NCPHI) is seeking to evaluate commercial products, or products in development, and services that are suitable for use in addressing the BioSense program's requirements for data acquisition, data analysis, data presentation and reporting, and use of data for a Public Health Response, as needed. BACKGROUND: BioSense is a CDC program to improve the nation's capabilities for real-time biosurveillance and health situational awareness. To that end, BioSense develops and implements enhanced capabilities to rapidly detect and monitor bioterrorism, natural disease outbreaks, and other events of public health importance. The primary objective is to expedite event recognition and response coordination among federal, state, and local public health and healthcare organizations by providing situational awareness to each level of public health through access to the same data, at the same time. BioSense achieves this by connecting existing health information to public health in a way not previously possible, by providing access to data from hospitals, healthcare systems, and other sources. Currently, the majority of health-related information systems that exist nationally vary in their ability to share data to support immediate biosurveillance needs. BioSense conducts near real-time biosurveillance and health situational awareness through access to existing data from these healthcare organizations across the country. Additionally, the BioSense Program provides access to the BioSense application, a web-based system for use by healthcare facilities and state and local public health partners. DESCRIPTION: The current BioSense operation spans four principal functions: - Data Acquisition - to assure the secure, timely, routine acquisition of health data for public health surveillance; - Data Analysis - to develop, evaluate, and apply analytic signal detection methodologies and algorithms and disseminate these methodologies to selected cities and states, to interpret the results of the analysis, in as close to real-time as possible; - Data Reporting - on a near real-time basis, provide useful views of the data, including time series analysis and geospatial displays, to colleagues in state and local health departments, hospital personnel, as well as to CDC programmatic staff; - Supporting Public Health Response - to provide local data to state and local partners and support their use and interpretation of these data for investigations, outbreak response and public health interventions. These functions are today provided through a loosely integrated set of services. BioSense seeks an integrated, end-to-end solution that encompasses a range of services including data source acquisition and relationship management, database design and management, hardware integration and deployment, software development and implementation, technical infrastructure support and maintenance, expert advisory services, and the required transition management. As of December 2006, approximately 350 facilities are sending data of various types to CDC including Foundational data (aligned with the AHIC Minimum Data Set), Emergency Department, Clinical, Micro, Radiology, and Pharmacy data. In addition, 466 Department of Defense and 863 Veterans Affairs outpatient clinics and emergency departments are sending data daily to CDC. Further, BioSense is in some stage of implementation with healthcare organizations or existing surveillance networks representing over 700 hospitals (including their EDs and in many cases their associated ambulatory care centers). In total, CDC has commitments from healthcare and existing systems representing more than 1,190 hospitals willing to transmit data to BioSense. CDC's implementation goals have been defined as follows: - Cumulative Hospitals: o 350 by end of calendar year 2006 o 1,450 by end of calendar year 2007 o 2,500 by end of calendar year 2008 o 3,500 by end of calendar year 2009 - Veterans Affairs(VA) and Department of Defense(DoD): Real-time data feeds to be complete in 2007 - Commercial laboratories: 3 largest commercial laboratories reporting microbiology results with data feeds complete in 2007 - Poison Control Centers: 62 poison control centers, data feeds complete in early 2007 In the near-term BioSense will focus on addressing six principal objectives: First, a focus on catastrophic public health emergencies, as opposed to routine public health outbreaks, given the high-risk of impact on morbidity and mortality; Second, a focus on enhancing biosurveillance capabilities for major metropolitan areas given their population size and corresponding high-risk; Third, a focus on achieving simultaneous data feeds from acute care hospitals to state and local public health departments as well as CDC; Fourth, assessing the comparative effectiveness and costs of different sub-network configurations for connecting healthcare entities and public health entities (e.g., links to individual hospitals, links to data-aggregation sites for hospital chains, and links to Regional Health Information Organizations or Health Information Exchanges; Fifth, field-testing the Minimum Data Set (MDS) accepted by the American Health Information Community (AHIC) to ascertain the feasibility of adoption and to determine where modifications are necessary and what form those should take; and Sixth, exercise of BioSense during the 2007/2008 seasonal influenza epidemic to determine whether "proof of concept" has been attained. RESPONSE: Data obtained from this RFI will be used by CDC in refining the acquisition strategy for the procurement of the next generation of BioSense services. Interested organizations that have candidate products and services are invited to submit a written response to CDC. As a minimum, submitted information should include: (a) A description of the respondent's approach to addressing the four principal functions of BioSense and the six near-term objectives; (b) A description of the expected challenges in executing these functions and achieving these objectives, and the manner in which the respondent's solution addresses these challenges; (c) A description of the technologies supporting the proposed approach; (d) A description of the critical factors for achieving success in execution of the functions and achievement of the objectives; and (e) A listing of the categories of prices and estimates of those prices on a per-unit basis, if readily available for commercial products or services, or an indication of the price estimate for products or services that are not readily available commercially. REMINDER: This is not a request for proposals. Supporting cost data is not required nor requested. Any pricing data provided, including estimates, is informational only and will be used to help formulate and refine the Government Cost Estimate for this requirement. This is an aspect of market research only. Providing pricing information is optional. All information submitted to CDC will be kept confidential as allowed by relevant federal law, including the Freedom of Information Act (5 USC 552) and the Trade Secrets Act (18 USC 1905). Information should be submitted by 12:00 p.m. (noon) on Monday, January 29, 2007. Responses should be limited to 12 pages, are preferred in electronic format, and can be e-mailed to the attention of the Contracting Officer: Vivian S. Hubbs, Phone 770-488-2647, email VHubbs@cdc.gov. If the Contracting Officer isn't available, please call the Team Leader, Lorenzo Falgiano.
 
Place of Performance
Address: Centers for Disease Control and Prevention (CDC), National Center for Public Health Informatics (NCPHI), 1600 Clifton Road, Atlanta, GA
Zip Code: 30329
Country: UNITED STATES
 
Record
SN01210916-W 20070114/070114185847 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.